Effects of Oral Levosimendan(ODM-109) on Respiratory Funcation in Patients with ALS: Open-Label Extension for Patients Completing Study 3119002

Project: Research project

StatusActive
Effective start/end date7/19/197/19/22

Funding

  • Pharmaceutical Research Associates, Inc. (Prot#3119003)
  • Orion Group (Prot#3119003)